Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

REPL

Replimune Group Inc

May 29 • 02:18PM ET

8.77

+4.09 87.39 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: CCCC CHRS ZNTL ALLO ALEC CLLS ELDN IMRX LENZ GLSI

| Held by: XBI IWM VTI IWN IBB VXF SCHA VTWO IWC DFAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.58	Insider Own	7.68%	Shs Outstand	79.63M	Perf Week	68.01%
Market Cap	724.16M	Forward P/E	-	EPS next Y	-1.63	Insider Trans	-1.75%	Shs Float	76.23M	Perf Month	268.49%
Enterprise Value	531.37M	PEG	-	EPS next Q	-0.66	Inst Own	102.43%	Short Float	31.03%	Perf Quarter	14.64%
Income	-314.85M	P/S	-	EPS this Y	0.28%	Inst Trans	-12.00%	Short Ratio	3.82	Perf Half Y	-7.97%
Sales	0.00M	P/B	3.32	EPS next Y	46.76%	ROA	-67.19%	Short Interest	23.66M	Perf YTD	-9.77%
Book/sh	2.64	P/C	2.69	EPS next 5Y	28.65%	ROE	-90.88%	52W High	13.24 -33.76%	Perf Year	-6.40%
Cash/sh	3.26	P/FCF	-	EPS past 3/5Y	-10.73% -14.85%	ROIC	-111.33%	52W Low	1.50 484.67%	Perf 3Y	-55.00%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.55% 14.79%	Perf 5Y	-77.50%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-13.96%	Oper. Margin	-	ATR (14)	0.83	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.60	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	76.02	Recom	3.50
Dividend Gr. 3/5Y	- -	Current Ratio	5.60	EPS Q/Q	3.16%	SMA20	94.28%	Beta	0.38	Target Price	2.20
Payout	-	Debt/Eq	0.36	Sales Q/Q	-	SMA50	85.69%	Rel Volume	9.68	Prev Close	4.68
Employees	479	LT Debt/Eq	0.34	Earnings	Feb 03 BMO	SMA200	29.16%	Avg Volume	6.19M	Price	8.77
IPO	Jul 20, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.89% 0.00%	Trades		Volume	45,041,503	Change	87.39%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)